Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
GGG vs ITW vs ROP vs EMR vs XYL
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
GGG vs ITW vs ROP vs EMR vs XYL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $13.06B | $73.64B | $36.28B | $79.02B | $27.49B |
| Revenue (TTM) | $2.25B | $16.22B | $8.12B | $18.32B | $9.09B |
| Net Income (TTM) | $516M | $3.13B | $1.71B | $2.44B | $973M |
| Gross Margin | 52.3% | 44.1% | 69.4% | 52.7% | 38.6% |
| Operating Margin | 26.9% | 26.4% | 28.1% | 19.8% | 13.6% |
| Forward P/E | 25.2x | 22.7x | 16.1x | 21.7x | 20.9x |
| Total Debt | $61M | $8.97B | $9.30B | $13.76B | $1.94B |
| Cash & Equiv. | $624M | $851M | $297M | $1.54B | $1.48B |
GGG vs ITW vs ROP vs EMR vs XYL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Graco Inc. (GGG) | 100 | 163.2 | +63.2% |
| Illinois Tool Works… (ITW) | 100 | 148.2 | +48.2% |
| Roper Technologies,… (ROP) | 100 | 89.5 | -10.5% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Xylem Inc. (XYL) | 100 | 174.3 | +74.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GGG vs ITW vs ROP vs EMR vs XYL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GGG ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.80, Low D/E 2.3%, current ratio 3.15x
- 23.0% margin vs XYL's 10.7%
ITW is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.67, yield 2.4%
- Beta 0.67, yield 2.4%, current ratio 1.21x
- 2.4% yield, 12-year raise streak, vs EMR's 1.5%
- 19.4% ROA vs ROP's 5.0%, ROIC 29.0% vs 6.1%
ROP carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 12.3%, EPS growth -1.0%, 3Y rev CAGR 13.7%
- 12.3% revenue growth vs ITW's 0.9%
- Lower P/E (16.1x vs 21.7x), PEG 1.68 vs 4.81
- Beta 0.43 vs EMR's 1.52, lower leverage
EMR is the clearest fit if your priority is long-term compounding.
- 206.6% 10Y total return vs GGG's 228.8%
- +30.4% vs ROP's -38.0%
XYL is the clearest fit if your priority is valuation efficiency.
- PEG 0.91 vs EMR's 4.81
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.3% revenue growth vs ITW's 0.9% | |
| Value | Lower P/E (16.1x vs 21.7x), PEG 1.68 vs 4.81 | |
| Quality / Margins | 23.0% margin vs XYL's 10.7% | |
| Stability / Safety | Beta 0.43 vs EMR's 1.52, lower leverage | |
| Dividends | 2.4% yield, 12-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +30.4% vs ROP's -38.0% | |
| Efficiency (ROA) | 19.4% ROA vs ROP's 5.0%, ROIC 29.0% vs 6.1% |
GGG vs ITW vs ROP vs EMR vs XYL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GGG vs ITW vs ROP vs EMR vs XYL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROP leads in 2 of 6 categories
EMR leads 1 • GGG leads 0 • ITW leads 0 • XYL leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ROP leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 8.1x GGG's $2.2B. GGG is the more profitable business, keeping 23.0% of every revenue dollar as net income compared to XYL's 10.7%. On growth, ROP holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $16.2B | $8.1B | $18.3B | $9.1B |
| EBITDAEarnings before interest/tax | $690M | $4.6B | $3.2B | $4.7B | $1.8B |
| Net IncomeAfter-tax profit | $516M | $3.1B | $1.7B | $2.4B | $973M |
| Free Cash FlowCash after capex | $631M | $2.2B | $2.6B | $3.1B | $966M |
| Gross MarginGross profit ÷ Revenue | +52.3% | +44.1% | +69.4% | +52.7% | +38.6% |
| Operating MarginEBIT ÷ Revenue | +26.9% | +26.4% | +28.1% | +19.8% | +13.6% |
| Net MarginNet income ÷ Revenue | +23.0% | +19.3% | +21.1% | +13.3% | +10.7% |
| FCF MarginFCF ÷ Revenue | +28.1% | +13.6% | +31.4% | +17.0% | +10.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.2% | +4.6% | +11.3% | +2.9% | +2.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.8% | +11.8% | +59.1% | +28.2% | +14.5% |
Valuation Metrics
ROP leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 24.4x trailing earnings, ITW trades at a 30% valuation discount to EMR's 34.9x P/E. Adjusting for growth (PEG ratio), XYL offers better value at 1.29x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $13.1B | $73.6B | $36.3B | $79.0B | $27.5B |
| Enterprise ValueMkt cap + debt − cash | $12.5B | $81.8B | $45.3B | $91.2B | $27.9B |
| Trailing P/EPrice ÷ TTM EPS | 25.54x | 24.36x | 24.82x | 34.92x | 29.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.15x | 22.68x | 16.08x | 21.71x | 20.91x |
| PEG RatioP/E ÷ EPS growth rate | 2.58x | 2.53x | 2.59x | 7.73x | 1.29x |
| EV / EBITDAEnterprise value multiple | 17.40x | 17.74x | 14.57x | 18.07x | 15.54x |
| Price / SalesMarket cap ÷ Revenue | 5.84x | 4.59x | 4.59x | 4.39x | 3.04x |
| Price / BookPrice ÷ Book value/share | 5.02x | 23.15x | 1.91x | 3.94x | 2.40x |
| Price / FCFMarket cap ÷ FCF | 20.47x | 27.20x | 14.55x | 29.63x | 30.21x |
Profitability & Efficiency
Evenly matched — GGG and ITW each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ITW delivers a 97.4% return on equity — every $100 of shareholder capital generates $97 in annual profit, vs $9 for XYL. GGG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITW's 2.78x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs ITW's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.7% | +97.4% | +8.8% | +12.1% | +8.5% |
| ROA (TTM)Return on assets | +16.0% | +19.4% | +5.0% | +5.8% | +5.6% |
| ROICReturn on invested capital | +22.6% | +29.0% | +6.1% | +8.2% | +7.6% |
| ROCEReturn on capital employed | +22.0% | +38.7% | +7.7% | +10.0% | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.02x | 2.78x | 0.47x | 0.68x | 0.17x |
| Net DebtTotal debt minus cash | -$563M | $8.1B | $9.0B | $12.2B | $463M |
| Cash & Equiv.Liquid assets | $624M | $851M | $297M | $1.5B | $1.5B |
| Total DebtShort + long-term debt | $61M | $9.0B | $9.3B | $13.8B | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | 209.82x | 14.53x | 6.50x | 6.46x | 49.32x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $15,945 today (with dividends reinvested), compared to $8,255 for ROP. Over the past 12 months, EMR leads with a +30.4% total return vs ROP's -38.0%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs ROP's -7.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.1% | +3.1% | -18.5% | +4.3% | -15.3% |
| 1-Year ReturnPast 12 months | -2.6% | +9.0% | -38.0% | +30.4% | -3.2% |
| 3-Year ReturnCumulative with dividends | +4.5% | +19.5% | -21.0% | +75.9% | +11.9% |
| 5-Year ReturnCumulative with dividends | +6.4% | +18.9% | -17.5% | +59.5% | +2.6% |
| 10-Year ReturnCumulative with dividends | +228.8% | +189.4% | +115.0% | +206.6% | +204.7% |
| CAGR (3Y)Annualised 3-year return | +1.5% | +6.1% | -7.6% | +20.7% | +3.8% |
Risk & Volatility
Evenly matched — ROP and EMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROP is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EMR currently trades 85.4% from its 52-week high vs ROP's 60.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 0.67x | 0.43x | 1.52x | 0.92x |
| 52-Week HighHighest price in past year | $95.69 | $303.16 | $584.03 | $165.15 | $154.27 |
| 52-Week LowLowest price in past year | $77.70 | $236.68 | $313.86 | $108.37 | $114.15 |
| % of 52W HighCurrent price vs 52-week peak | +82.2% | +84.3% | +60.3% | +85.4% | +75.0% |
| RSI (14)Momentum oscillator 0–100 | 40.0 | 45.3 | 43.6 | 61.3 | 45.4 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 1.2M | 1.2M | 2.8M | 2.1M |
Analyst Outlook
Evenly matched — ITW and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GGG as "Hold", ITW as "Hold", ROP as "Buy", EMR as "Buy", XYL as "Hold". Consensus price targets imply 31.1% upside for XYL (target: $152) vs 7.1% for ITW (target: $274). For income investors, ITW offers the higher dividend yield at 2.39% vs ROP's 0.93%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $95.67 | $273.67 | $457.64 | $161.92 | $151.57 |
| # AnalystsCovering analysts | 20 | 28 | 23 | 41 | 40 |
| Dividend YieldAnnual dividend ÷ price | +1.4% | +2.4% | +0.9% | +1.5% | +1.4% |
| Dividend StreakConsecutive years of raises | 20 | 12 | 12 | 37 | 15 |
| Dividend / ShareAnnual DPS | $1.08 | $6.11 | $3.29 | $2.10 | $1.60 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.2% | +2.0% | +1.4% | +1.6% | +0.1% |
ROP leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). EMR leads in 1 (Total Returns). 3 tied.
GGG vs ITW vs ROP vs EMR vs XYL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GGG or ITW or ROP or EMR or XYL a better buy right now?
For growth investors, Roper Technologies, Inc.
(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 0. 9% for Illinois Tool Works Inc. (ITW). Illinois Tool Works Inc. (ITW) offers the better valuation at 24. 4x trailing P/E (22. 7x forward), making it the more compelling value choice. Analysts rate Roper Technologies, Inc. (ROP) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GGG or ITW or ROP or EMR or XYL?
On trailing P/E, Illinois Tool Works Inc.
(ITW) is the cheapest at 24. 4x versus Emerson Electric Co. at 34. 9x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 16. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Xylem Inc. wins at 0. 91x versus Emerson Electric Co. 's 4. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GGG or ITW or ROP or EMR or XYL?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +59. 5%, compared to -17. 5% for Roper Technologies, Inc. (ROP). Over 10 years, the gap is even starker: GGG returned +228. 8% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GGG or ITW or ROP or EMR or XYL?
By beta (market sensitivity over 5 years), Roper Technologies, Inc.
(ROP) is the lower-risk stock at 0. 43β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 256% more volatile than ROP relative to the S&P 500. On balance sheet safety, Graco Inc. (GGG) carries a lower debt/equity ratio of 2% versus 3% for Illinois Tool Works Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GGG or ITW or ROP or EMR or XYL?
By revenue growth (latest reported year), Roper Technologies, Inc.
(ROP) is pulling ahead at 12. 3% versus 0. 9% for Illinois Tool Works Inc. (ITW). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -10. 4% for Illinois Tool Works Inc.. Over a 3-year CAGR, XYL leads at 17. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GGG or ITW or ROP or EMR or XYL?
Graco Inc.
(GGG) is the more profitable company, earning 23. 3% net margin versus 10. 6% for Xylem Inc. — meaning it keeps 23. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 13. 5% for XYL. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GGG or ITW or ROP or EMR or XYL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Xylem Inc. (XYL) is the more undervalued stock at a PEG of 0. 91x versus Emerson Electric Co. 's 4. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 16. 1x forward P/E versus 25. 2x for Graco Inc. — 9. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XYL: 31. 1% to $151. 57.
08Which pays a better dividend — GGG or ITW or ROP or EMR or XYL?
All stocks in this comparison pay dividends.
Illinois Tool Works Inc. (ITW) offers the highest yield at 2. 4%, versus 0. 9% for Roper Technologies, Inc. (ROP).
09Is GGG or ITW or ROP or EMR or XYL better for a retirement portfolio?
For long-horizon retirement investors, Roper Technologies, Inc.
(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 43), 0. 9% yield, +115. 0% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ROP: +115. 0%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GGG and ITW and ROP and EMR and XYL?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.